Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-25-029526
Filing Date
2025-09-19
Accepted
2025-09-19 17:13:09
Documents
24

Document Format Files

Seq Description Document Type Size
1 FORM S-3 mbrx20250916_s3.htm   iXBRL S-3 189908
2 EXHIBIT 5.1 ex_862073.htm EX-5.1 12769
3 EXHIBIT 23.1 ex_863057.htm EX-23.1 2211
4 EXHIBIT FILING FEES ex_862072.htm   iXBRL EX-FILING FEES 25493
9 ex_862073img002.jpg GRAPHIC 3326
10 ex_862073img003.jpg GRAPHIC 3326
11 logobig.jpg GRAPHIC 19220
  Complete submission text file 0001437749-25-029526.txt   577312

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20250630.xsd EX-101.SCH 5412
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20250630_def.xml EX-101.DEF 12505
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20250630_lab.xml EX-101.LAB 26386
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20250630_pre.xml EX-101.PRE 12830
26 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20250916_s3_htm.xml XML 2729
27 EXTRACTED XBRL INSTANCE DOCUMENT ex_862072_htm.xml XML 4871
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-290418 | Film No.: 251327638
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)